2-Fluoro-N-methyl-4-nitrobenzamide

It allows for the introduction of the necessary fluorinated aromatic ring, which is subsequently reduced and coupled to form the active drug’s core structure. 2-Fluoro-N-methyl-4-nitrobenzamide is a key intermediate in the synthesis of Enzalutamide, a medication for castration-resistant prostate cancer, typically used as a precursor to 4-amino-2-fluoro-N-methylbenzamide.